Skip to content
All news
Analysis

Pfizer's Dividend Yield Is 10X Bigger Than Eli Lilly's: Does That Make It the Better Income Stock?

Pfizer's dividend yield stands at approximately 5.8%, ten times higher than Eli Lilly's 0.6%. However, Pfizer faces operational headwinds, while Eli Lilly enjoys strong growth.

June 20, 2026
2 min read
Source: Motley Fool
Share:

Key Numbers

pfizer dividend yield
approximately 5.8%
eli lilly dividend yield
approximately 0.6%

According to a report from Motley Fool, a comparative analysis between pharmaceutical giants Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) reveals a significant gap in dividend yields. While Pfizer offers a yield of approximately 5.8%, Eli Lilly's yield is only about 0.6%, making Pfizer's yield ten times larger.

Recommendation Change

No change in analyst recommendations was reported; this is a comparative analysis highlighting the yield difference.

Analyst Rationale

Analysts note that Pfizer offers an attractive yield for income investors but faces headwinds from declining COVID-19 product sales and patent expirations on key drugs. In contrast, Eli Lilly is experiencing strong growth driven by new drugs like Mounjaro and Zepbound, reducing its need for high dividend payouts.

Context

Pfizer's stock has underperformed recently, while Eli Lilly's shares have risen significantly. Other analysts recommend Pfizer as a value opportunity, while focusing on growth for Eli Lilly.

Conclusion

The choice depends on investor goals: for steady income, Pfizer may be suitable despite risks; for capital appreciation, Eli Lilly might be preferable.

Frequently Asked Questions

Pfizer's dividend yield is approximately 5.8%.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.